CFDE Data Portal | Search MIR3945HG

	Label	Description
	MIR3945HG Gene (Entity type)	ENSG00000251230 - MIR3945 host gene
	GSE93156 idelalisib B cell 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146612 amiodarone 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209698 calcitriol D 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE141143 BTK KLHL14 knockout TMD8 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128885 deferiprone macrophage 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR3945HG

ENSG00000251230 - MIR3945 host gene

GSE93156 idelalisib B cell 1 v 0 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human up

A Gene Set from LINCS

GSE239844 crizotinib 8 v 10 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE146612 amiodarone 2 v 3 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 1 human up

A Gene Set from LINCS

GSE209698 calcitriol D 2 v 1 human up

A Gene Set from LINCS

GSE141143 BTK KLHL14 knockout TMD8 1 v 0 human dn

A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.